SynthesisReviews in cardiovascular medicine2025
Perioperative Risk Factors for Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
Synthesis in Reviews in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Transcatheter aortic valve replacement (TAVR) has become the preferred treatment for severe aortic stenosis, particularly in patients at high surgical risk. Conduction block requiring permanent pacemaker (PPM) implantation remains a common complication post-TAVR. This systematic review and meta-analysis aimed to clarify perioperative (≤30-day) predictors of PPM implantation. Methods: A systematic search was performed using the PubMed, Web of Science, and Embase databases to gather all relevant studies examining the relationship between TAVR and pacemaker implantation outcomes within 30 days of the procedure. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Results: A total of 82 studies comprising 124,808 patients were included. The overall incidence of PPM implantation within 30 days post-TAVR was 17.5%. Key baseline risk factors included right bundle branch block (RBBB) (OR, 5.48; 95% CI, 4.52-6.64) and first-degree atrioventricular block (AVB) (OR, 2.30; 95% CI, 1.82-2.90). Baseline left bundle branch block (LBBB), mitral annular calcification, and male sex were not significantly associated with PPM implantation. A longer membranous septum (MS) length was associated with a reduced risk (OR, 0.78; 95% CI, 0.66-0.93). Additionally, procedural risk factors included greater implant depth (OR, 1.20; 95% CI, 1.13-1.28), the use of self-expanding valves (OR, 2.59; 95% CI, 2.06-3.27), and balloon predilation (OR, 1.37; 95% CI, 1.10-1.71). The cusp overlap technique (COT) significantly reduced PPM risk (OR, 0.45; 95% CI, 0.35-0.58). Furthermore, a greater difference between MS length and implantation depth (ΔMSID) was inversely correlated with PPM implantation risk (OR, 1.36; 95% CI, 1.22-1.50), and post-TAVR new-onset LBBB was a strong predictor of PPM implantation (OR, 2.26; 95% CI, 1.66-3.07). Conclusions: This meta-analysis identified key perioperative predictors of PPM implantation following TAVR. RBBB, first-degree AVB, increased implant depth, self-expanding valves, and predilation all have been shown to increase PPM risk, whereas COT and lower ΔMSID are protective factors. The PROSPERO Registration: CRD42023438228, URL: https://www.crd.york.ac.uk/PROSPERO/view/CRD42023438228.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.